Defective protein responsible for SCA5 disease cuts synaptic terminals and snarls traffic inside neurons

NewsGuard 100/100 Score

The neurodegenerative disease spinocerebellar ataxia type 5 (SCA5) damages nerve cells in two ways. University of Minnesota researchers now report that the defective protein responsible for the disease cuts the number of synaptic terminals and snarls traffic inside neurons. The study appears in the April 5 issue of the Journal of Cell Biology (www.jcb.org).

SCA5 results from a faulty gene for {beta}-III-spectrin. The disease targets the cerebellum's Purkinje cells, which control coordination. Symptoms usually start when patients are in their 20s or 30s, and they can gradually lose the ability to walk and speak. How the mutant protein damages Purkinje cells remains uncertain. {beta}-III-spectrin stabilizes synapses, suggesting that synapse deterioration might doom the cells. But the protein also helps the adapter protein dynactin hitch cargoes to dynein motors, pointing to a disruption of intracellular transportation.

Lorenzo et al. found support for both mechanisms. They engineered fruit flies to carry a mutated {beta}-III spectrin gene from either of two human families affected with SCA5, including one descended from Abraham Lincoln's paternal grandparents (whether Lincoln himself had the disease isn't clear). Fly larvae with the mutated gene had paralyzed tails. At the neuromuscular junctions where nerves and muscles meet, the larvae showed fewer presynaptic terminals.

The researchers next tracked the movement of synaptic vesicles in axons from the animals. Vesicles from flies that made the faulty {beta}-III-spectrin were slower and more likely to change direction, and thus traveled shorter distances. Other neurodegenerative diseases, including Alzheimer's disease and amyotrophic lateral sclerosis, involve faulty transport, and the results indicate that SCA5 does too.

The two mechanisms might have a common link, the researchers suggest. The complex containing {beta}-III-spectrin, dynactin, and dynein might not just haul cargoes. At the synapse it might snag microtubules that strengthen the membrane and prevent degeneration.

Source: Rockefeller University Press

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
An ActRIIA fusion protein got FDA approved for PAH treatment